Table 4.

Recurrence-free survival analysis of 125 bladder cancer patients

polymorphisms	genotype	N (all, n = 125)	N (reoccurence, n = 71)	HR (95% CI)
Rs2675	AA	83 (66.4%)	48 (57.8%)	1
	AC	37 (29.6%)	20 (54.1%)	0.858 (0.393, 1.871)
	CC	5(4.0%)	3 (60.0%)	1.094 (0.173, 6.897)
Rs1062484	CC	120 (96.0%)	70 (58.3%)	1
	CT	5 (4.0%)	1 (20.0%)	0.179 (0.019, 1.646)
Rs11902171	GG	99 (79.2%)	56 (56.6%)	1
	GC	25 (20.0%)	14 (56.0%)	0.977 (0.404, 2.366)
	CC	1 (0.8%)	1 (100.0%)	—
Rs17664	GG	91 (72.8%)	53 (58.2%)	1
	GA	32 (25.6%)	17 (53.1%)	0.813 (0.362, 1.826)
	AA	2 (1.6%)	1 (50.0%)	0.717 (0.043, 11.825)